Munoz-Zabaleta M, Garzon Rodriguez N, Diaz-Barrera L, Quiroz-Padilla M
Metabolites. 2025; 15(2).
PMID: 39997758
PMC: 11857725.
DOI: 10.3390/metabo15020133.
Nova L, Poinhos R, Teixeira B
Porto Biomed J. 2024; 9(6):276.
PMID: 39633961
PMC: 11608746.
DOI: 10.1097/j.pbj.0000000000000276.
Visternicu M, Rarinca V, Burlui V, Halitchi G, Ciobica A, Singeap A
Nutrients. 2024; 16(18).
PMID: 39339712
PMC: 11435085.
DOI: 10.3390/nu16183113.
Gillies D, Leach M, Perez Algorta G
Cochrane Database Syst Rev. 2023; 4:CD007986.
PMID: 37058600
PMC: 10103546.
DOI: 10.1002/14651858.CD007986.pub3.
Yildiz Miniksar D, Cansiz M, Gocmen A, Kilic M, Miniksar O
Clin Psychopharmacol Neurosci. 2023; 21(1):88-98.
PMID: 36700315
PMC: 9889889.
DOI: 10.9758/cpn.2023.21.1.88.
The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial.
Khoshbakht Y, Moghtaderi F, Bidaki R, Hosseinzadeh M, Salehi-Abargouei A
Eur J Nutr. 2021; 60(7):3647-3658.
PMID: 33715085
DOI: 10.1007/s00394-021-02527-x.
Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder.
Alvarez-Arellano L, Gonzalez-Garcia N, Salazar-Garcia M, Corona J
Antioxidants (Basel). 2020; 9(2).
PMID: 32098021
PMC: 7070894.
DOI: 10.3390/antiox9020176.
Relationship between Antioxidant Status and Attention Deficit Hyperactivity Disorder Among Children.
Nasim S, Naeini A, Najafi M, Ghazvini M, Hassanzadeh A
Int J Prev Med. 2019; 10:41.
PMID: 31057726
PMC: 6484508.
DOI: 10.4103/ijpvm.IJPVM_80_18.
Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.
Verlaet A, Breynaert A, Ceulemans B, De Bruyne T, Fransen E, Pieters L
Eur Child Adolesc Psychiatry. 2018; 28(5):719-729.
PMID: 30350094
DOI: 10.1007/s00787-018-1239-4.
The potential relevance of docosahexaenoic acid and eicosapentaenoic acid to the etiopathogenesis of childhood neuropsychiatric disorders.
Tesei A, Crippa A, Ceccarelli S, Mauri M, Molteni M, Agostoni C
Eur Child Adolesc Psychiatry. 2016; 26(9):1011-1030.
PMID: 27988864
DOI: 10.1007/s00787-016-0932-4.
Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment.
Konigs A, Kiliaan A
Neuropsychiatr Dis Treat. 2016; 12:1869-82.
PMID: 27555775
PMC: 4968854.
DOI: 10.2147/NDT.S68652.
Sugar-Sweetened Beverage Consumption Is Adversely Associated with Childhood Attention Deficit/Hyperactivity Disorder.
Yu C, Du J, Chiou H, Feng C, Chung M, Yang W
Int J Environ Res Public Health. 2016; 13(7).
PMID: 27384573
PMC: 4962219.
DOI: 10.3390/ijerph13070678.
Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
Parletta N, Niyonsenga T, Duff J
PLoS One. 2016; 11(5):e0156432.
PMID: 27232999
PMC: 4883772.
DOI: 10.1371/journal.pone.0156432.
Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.
Ahn J, Ahn H, Cheong J, Dela Pena I
Neural Plast. 2016; 2016:1320423.
PMID: 26966583
PMC: 4757677.
DOI: 10.1155/2016/1320423.
The effect of alpha-linolenic acid supplementation on ADHD symptoms in children: a randomized controlled double-blind study.
Dubnov-Raz G, Khoury Z, Wright I, Raz R, Berger I
Front Hum Neurosci. 2014; 8:780.
PMID: 25339885
PMC: 4188038.
DOI: 10.3389/fnhum.2014.00780.
Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials.
Hawkey E, Nigg J
Clin Psychol Rev. 2014; 34(6):496-505.
PMID: 25181335
PMC: 4321799.
DOI: 10.1016/j.cpr.2014.05.005.
Docosahexaenoic acid content is significantly higher in ghrita prepared by traditional Ayurvedic method.
Joshi K
J Ayurveda Integr Med. 2014; 5(2):85-8.
PMID: 24948858
PMC: 4061595.
DOI: 10.4103/0975-9476.131730.
ROS and brain diseases: the good, the bad, and the ugly.
Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga A
Oxid Med Cell Longev. 2014; 2013:963520.
PMID: 24381719
PMC: 3871919.
DOI: 10.1155/2013/963520.
Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?.
Behdani F, Hebrani P, Naseraee A, Baghban Haghighi M, Akhavanrezayat A
J Res Med Sci. 2014; 18(8):653-8.
PMID: 24379840
PMC: 3872603.
Use of natural health products in children: survey of parents in waiting rooms.
Godwin M, Crellin J, Mathews M, Chowdhury N, Newhook L, Pike A
Can Fam Physician. 2013; 59(8):e364-71.
PMID: 23946043
PMC: 3743713.